Fenfluramine Completed Phase 2 Trials for Vascular Diseases / Heart Diseases / BMI >30 kg/m2 Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00000506Cardiovascular System in Obesity: Effect of Treatment